Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Electronic recall notifications

Executive Summary

FDA is encouraging electronic distribution of product information, including recall notifications and drug safety information, in a draft guidance released in the Federal Register Sept. 30. The guidance, "Using Electronic Means to Distribute Certain Product Information," provides information on alternative forms of communications outside of those currently included in regulations. "An increasing number of healthcare providers utilize e-mail and other electronic methods to receive information and conduct business activities," the guidance states...

You may also be interested in...

Electronic “Dear Doctor” Network Signs Up 40,000 Physicians

The fledgling Health Care Notification Network -designed to distribute "Dear Doctor" letters from manufacturers with safety alerts via e-mail - aims to sign up about 100,000 physicians to secure a critical mass for the program's success

Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.

venBio Raises $394m To Fund Biopharmas Through Human Proof-Of-Concept

Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts